Arkolith/Insider Trading/CMPX/Form 4

Schuetz Thomas J.

President of R&D, DirectorCompass Therapeutics, Inc. (CMPX) · full profile →Form 4 · filed Jan 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2024Grant(A)638K$1.93$1.2M6.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 9, 2024Grant(A)638K—$0638K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-24-000178) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML